Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ClaritevMPLNW 64 FCF Margin % is 21.20% as of Jun. 2026, which is 4% below its 10-year median of 22.08. GuruFocus rates MPLNW with a GF Score™ of 64/100. The stock has 6 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Claritev ranks worse than 67.57% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Claritev's Free Cash Flow for the
three
months ended in Jun. 2026 was $54.59 Mil. Claritev's Revenue for the
three
months ended in Jun. 2026 was $257.48 Mil. Therefore, Claritev's FCF Margin % for the quarter that ended in Jun. 2026 was 21.20%.
The historical rank and industry rank for Claritev's FCF Margin % or its related term are showing as below:
During the past 8 years, the highest FCF Margin % of Claritev was 32.69%. The lowest was -1.27%. And the median was 22.08%.
MPLNW's FCF Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 3.025 * Ranked among companies with meaningful FCF Margin % only.
The historical data trend for Claritev's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Claritev's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Claritev FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Claritev's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Claritev's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Claritev (MPLNW) has a FCF Margin % of 21.20% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Claritev and its competitors. This is near median its historical median of 22.08. According to the industry distribution chart, Claritev ranks #450 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 67.6%.
Is Claritev's FCF Margin % too high?
Claritev's current FCF Margin % of 21.20% is near median its 10-year median of 22.08. The Healthcare Providers & Services industry median FCF Margin % is 3.03. Claritev's value of 21.20% is 600.8% above this industry median. Based on the distribution chart, Claritev ranks #450 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Claritev has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Claritev's FCF Margin % compare to SLP and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Claritev ranks #450 out of 666 companies for FCF Margin %. This places Claritev in the lower half of its industry. The industry median FCF Margin % is 3.03. Claritev's value of 21.20% is 600.8% above this benchmark. While the company's 10-year median is 22.08 vs. the industry median of 3.03, Claritev has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.03, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Claritev's current FCF Margin % of 21.20% is 600.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Claritev and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Claritev's current FCF Margin % is 21.20%, which is near median its own 10-year median of 22.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Claritev stock overvalued right now?
Claritev (MPLNW) has a current FCF Margin % of 21.20%. The current FCF Margin % is 21.20%, which is near median its 10-year median of 22.08 and 600.8% above the Healthcare Providers & Services industry median of 3.03. Claritev's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Claritev (MPLNW), the current FCF Margin % is 21.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
64GF Score
Get the complete analysis for MPLNW
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MPLNW has been successfully added to your 
